However, in a study with RA patients treated with abatacept or adalimumab, no association between the MBDA test result and other previously mentioned disease activity measures (CDAI, SDAI, DAS28-CRP, RAPID3) has been found [11]. Here, CRP is linked to rheumatoid arthritis.